F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on review of the medical record, review of controlled substance administration records, review of
medication administration records, staff interview, and policy review, the facility failed to ensure medications
were administered per physician orders and failed to ensure an accurate system of dispensing and
administering controlled substances. This affected three (#77, #26, #18) of three residents reviewed for
medication administration. The facility census was 76.
Finding include:
1. Review of the medical record for Resident #77 revealed an admission date on 06/21/23, a readmission
date of 10/06/23, and a discharge date of 04/20/24. Diagnoses included acute on chronic respiratory failure
with hypoxia, atrial fibrillation, congestive heart failure, chronic obstructive pulmonary disease, dysphagia,
obstructive sleep apnea, hypertension, and chronic pain syndrome.
Review of the physician's orders dated 04/13/24 revealed the resident had orders for lorazepam tablet 0.5
milligrams (mg) by mouth every four hours as needed. Review of a physician order dated 04/14/24,
revealed orders for morphine sulfate solution 20 mg/milliliter (ml), give two mg by mouth every two hours as
needed for pain, and a physician order dated 04/11/24, for hydrocodone/acetaminophen 5/325 mg every
four hours as needed for pain.
Review of the controlled substance administration record (CSAR) revealed five doses of lorazepam were
removed as follows: on 04/13/24 at 3:35 P.M. and 10:30 P.M.; on 04/14/24 at 11:00 A.M., on 04/17/24 at
4:00 P.M.; and on 04/18/24 at 2:45 P.M.; however, the medications were not documented as administered
on the medication administration record (MAR).
Further review of the CSAR revealed 0.1 ml of morphine was removed as follows: on 04/13/24 at 7:43 A.M.;
on 04/14/24 at 10:00 A.M. and 3:35 P.M.; on 04/15/24 at 8:53 P.M.; and on 04/18/24 at 8:00 P.M.; however,
not documented as administered on the MAR. Further review of the MAR revealed one dose of morphine
was administered on 04/14/24 but was never documented on the CSAR.
Continued review of the CSAR revealed 16 doses of hydrocodone/acetaminophen 5/325 mg were removed
as follows: on 04/01/24 at 1:00 P.M., 8:00 P.M.; on 04/02/24 at 1:00 A.M.; on 04/04/24 at 9:00 A.M., and
3:36 P.M.; on 04/05/24 at 12:00 A.M.; on 04/06/24 at 3:42 P.M.; on 04/07/24 at 7:00 P.M.; on 04/08/24 at
6:00 P.M.; on 04/09/24 at 4:00 A.M., 9:00 A.M., and 7:00 P.M.; on 04/10/24 at 4:00 P.M. and 10:00 P.M.; on
04/11/24 at 8:00 P.M.; and on 04/12/24 at 4:00 P.M. These medications were never documented as
administered on the MAR.
2. Review of the medical record for Resident #26 revealed an admission date of 04/19/19. Diagnoses
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
365737
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/23/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Heatherdowns Rehab & Residential Care Center
2401 Cass Rd
Toledo, OH 43614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
included chronic obstructive pulmonary disease, hypertension, and peripheral vascular disease.
Level of Harm - Minimal harm
or potential for actual harm
Review of the monthly physician orders for April 2024 revealed an order for lorazepam 0.5 mg every fours
as needed for agitation until 07/31/24; morphine sulfate 20 mg/ml, give two mg every two hours as needed
for pain or shortness of breath; and tramadol 50 mg, one tablet by mouth every six hours for pain.
Residents Affected - Few
Review of the CSAR for tramadol 50 mg revealed doses were removed from the card as follows: on
04/01/24 at 4:30 P.M. and 04/09/24, 04/10/24, and 04/11/24, and the medications were not documented as
administered on the MAR. Additional review of the MAR revealed there was documentation that 20 doses of
tramadol were administered: on 04/14/24 at 12:00 P.M.; on 04/21/24 at 6:00 P.M.; on 05/03/24 at 12:00 A.M.
and 6:00 A.M.; on 05/04/24 at 12:00 A.M., on 6:00 A.M. and 6:00 P.M.; on 05/06/24 at 6:00 P.M.; on
05/07/24 at 12:00 A.M. and 12:00 P.M.; on 05/09/24 at 12:00 P.M.; on 05/12/24 at 12:00 A.M., 6:00 A.M.,
12:00 P.M.; on 05/14/24 at 12:00 P.M.; on 05/15/24 at 6:00 P.M.; on 05/16/24 at 12:00 P.M.; on 05/17/24 at
12:00 P.M.; and on 05/20/24 at 12:00 A.M. and 6:00 P.M. The 20 medication doses were not documented
on the CSAR to be administered.
Review of the CSAR revealed one dose of morphine sulfate 100 mg/5 ml was removed on 05/06/24 at 9:00
P.M., and the medication was never documented as administered on the MAR.
Review of the CSAR revealed 11 doses of lorazepam 0.5 mg was removed to be administered as follows:
on 04/18/24 at 4:00 P.M.; on 04/22/24 at 12:00 P.M.; on 04/23/24 at 7:00 P.M.; on 04/26/24 at 4:00 P.M. and
7:00 P.M.; on 05/02/24 at 6:00 P.M.; on 05/04/24 at 6:00 P.M.; on 05/06/24 at 4:00 A.M.; on 05/07/24 at 8:00
A.M.; and on 05/13/24 at 6:00 P.M. The medications were not documented as administered on the MAR.
3. Review of the medical record for Resident #18 revealed an admission date of 05/16/24. Diagnoses
included type two diabetes mellitus, hypertension, stage four pressure ulcer of the right hip, and chronic
pain.
Review of the admission physician orders for Resident #18 revealed an order for morphine sulfate oral
solution 20 mg/ml, give 0.25 ml by mouth every one hour as needed for pain. Review of a physician order
dated 05/19/24 revealed an order for lorazepam tablet one (1) mg every four hours as needed for
restlessness and anxiety.
Review of the CSAR revealed there were five doses of morphine sulfate solution 100 milligrams (mg)/five
milliliters (ml) removed and only two of the doses had a nurse signature. The doses signed out on 05/18/24
and 05/19/24 were not recorded as administered on the MAR.
Review of the CSAR for lorazepam tablet one milligram revealed on 05/17/24 one dose was signed out on
the CSAR but not documented as administered on the MAR.
Interview on 05/22/24 at 12:03 P.M., with Licensed Practical Nurse (LPN) #109 revealed when giving a
narcotic medication: the count should be verified, then pull the medication from the drawer and sign out the
medication on both the MAR and the CSAR. LPN #109 revealed she was recently in-service on correct
procedures for pulling and administering controlled substances along with proper documentation in the
MAR and CSAR.
Interview on 05/23/24 beginning at 9:50 A.M., with the Director of Nursing (DON) verified nine
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365737
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365737
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/23/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Heatherdowns Rehab & Residential Care Center
2401 Cass Rd
Toledo, OH 43614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
nurses had not documented narcotic medications as administered on the MAR and/or had documented
narcotic medications as administered but were never removed from the CSAR to be administered for
Resident #77, Resident #26, and Resident #18.
Review of the policy titled, Medication Administration, dated 06/21/17, revealed medication would be
administered by legally authorized and trained persons in accordance to applicable State, Local and
Federal laws and consistent with accepted standards of practice. Further review of the policy revealed after
administering medications, return to the medication cart and document medication administration with
initials on the Medication Administration Record (MAR) immediately after administering medication to each
resident.
This deficiency represents non-compliance investigation under Master Complaint Number OH00153619,
Complaint Number OH00153565, and Complaint Number OH00153605.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365737
If continuation sheet
Page 3 of 3